Joel Sendek is the founder of Dewpoint Therapeutics. Dewpoint Therapeutics has raised $287M in total funding. Latest round: Series C. Based in Boston, MA.
Joel Sendek is the Chief Financial Officer at Dewpoint Therapeutics, a company focused on biomolecular condensates. He has a background as a Wall Street analyst and has served as CFO at multiple biotech companies, overseeing transactions and fundraising efforts.
Full founder directory · Investor directory · Company funding database · Fundraising library